Eurican Herpes 205
Canine herpes vaccine (inactivated subunit)
Table of contents
Overview
Eurican Herpes 205 is a veterinary vaccine used to immunise pregnant bitches to prevent mortality, clinical signs and lesions in puppies caused by canine herpes virus infections acquired in the first few days of life.
Eurican Herpes 205 contains the active substance canine herpes virus (F205 strain) antigens.
Authorisation details
Product details | |
---|---|
Name |
Eurican Herpes 205
|
Agency product number |
EMEA/V/C/000059
|
Active substance |
Canine herpesvirus (F205 strain) antigens
|
International non-proprietary name (INN) or common name |
Canine herpes vaccine (inactivated subunit)
|
Species |
Dogs
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI07AA
|
Publication details | |
---|---|
Marketing-authorisation holder |
Boehringer Ingelheim Vetmedica GmbH
|
Revision |
12
|
Date of issue of marketing authorisation valid throughout the European Union |
26/03/2001
|
Contact address |
Binger Strasse 173 |
Product information
14/08/2020 Eurican Herpes 205 - EMEA/V/C/000059 - IG/1279
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Immunologicals for canidae
Therapeutic indication
Active immunisation of bitches to prevent mortality, clinical signs and lesions in puppies resulting from canine herpes virus infections acquired in the first few days of life.